X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
index medicus (11) 11
female (10) 10
male (9) 9
middle aged (7) 7
adult (6) 6
abridged index medicus (5) 5
treatment outcome (5) 5
aged (4) 4
drug therapy (4) 4
genotype (4) 4
medicine, general & internal (4) 4
abt-450/r-ombitasvir (3) 3
antiviral agents - therapeutic use (3) 3
drug therapy, combination (3) 3
health aspects (3) 3
hepacivirus - genetics (3) 3
hepatitis c, chronic - drug therapy (3) 3
medical research (3) 3
prevalence (3) 3
quality of life (3) 3
ribavirin (3) 3
virus diseases (3) 3
activation (2) 2
adolescent (2) 2
anilides - administration & dosage (2) 2
anilides - therapeutic use (2) 2
article (2) 2
biological response modifiers (2) 2
carbamates - administration & dosage (2) 2
carbamates - therapeutic use (2) 2
care and treatment (2) 2
cholesterol (2) 2
clinical medicine (2) 2
dasabuvir (2) 2
double-blind method (2) 2
dyskinesia (2) 2
evaluation (2) 2
gene sequencing (2) 2
genome-wide association study (2) 2
genomes (2) 2
hepacivirus - drug effects (2) 2
hepatitis c virus (2) 2
hepatitis c, chronic - virology (2) 2
identification (2) 2
infections (2) 2
infusion (2) 2
inhibitor (2) 2
klinisk medicin (2) 2
ledipasvir (2) 2
levodopa-carbidopa intestinal gel (2) 2
lipids - blood (2) 2
liver (2) 2
liver cirrhosis (2) 2
macrocyclic compounds - administration & dosage (2) 2
macrocyclic compounds - therapeutic use (2) 2
pediatrics (2) 2
percutaneous endoscopic gastrojejunostomy (2) 2
physical examinations (2) 2
prospective studies (2) 2
proteases (2) 2
quality-of-life (2) 2
research articles (2) 2
risk (2) 2
ritonavir - administration & dosage (2) 2
ritonavir - therapeutic use (2) 2
science (2) 2
sofosbuvir (2) 2
united states (2) 2
viruses (2) 2
young adult (2) 2
“off” time (2) 2
"off" time (1) 1
3111 biomedicine (1) 1
599 (1) 1
actresses (1) 1
adhd (1) 1
administration, oral (1) 1
adrenergic uptake inhibitors - administration & dosage (1) 1
adrenergic uptake inhibitors - adverse effects (1) 1
adults (1) 1
age (1) 1
aged, anti-inflammatory agents, antibodies, monoclonal, atherosclerosis, c-reactive protein, cardiovascular diseases, dose-response relationship, drug, double-blind method, female, humans, incidence, infection, interleukin-1beta, lipids, male, middle aged, myocardial infarction, neutropenia, secondary prevention, stroke (1) 1
airway hyperresponsiveness (1) 1
al eskan disease (1) 1
alanine transaminase - drug effects (1) 1
alleles (1) 1
alpha 4 beta 2 (1) 1
amino acid sequence (1) 1
amiodarone (1) 1
analysis (1) 1
angina (1) 1
angina pectoris (1) 1
anilides - adverse effects (1) 1
antagonists (1) 1
anti-arrhythmia agents - adverse effects (1) 1
anti-arrhythmia agents - therapeutic use (1) 1
anti-inflammatory agents - administration & dosage (1) 1
anti-inflammatory agents - adverse effects (1) 1
antibodies, monoclonal - administration & dosage (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2502 - 2509
Journal Article
Journal Article
by Arno, Gavin and Carss, Keren and Carss, Keren J and Hull, Sarah and Zihni, Ceniz and Robson, Anthony G and Fiorentino, Alessia and Black, Graeme and Hall, Georgina and Ingram, Stuart and Gillespie, Rachel and Manson, Ania and Manson, Forbes and Sergouniotis, Panagiotis and Inglehearn, Chris and Toomes, Carmel and Ali, Sonia and Ali, Manir and McKibbin, Martin and Poulter, James and Khan, Kamron and Lord, Emma and Nemeth, Andrea and Downes, Susan and Halford, Stephanie and Yu, Ping and Yu, Jing and Lise, Stefano and Ponitkos, Nikos and Plagnol, Vincent and Michaelides, Michel and Hardcastle, Alison J and Cheetham, Michael E and Webster, Andrew and Webster, Andrew R and van Heyningen, Veronica and Holder, Graham E and Holder, Susan and Holder, Muriel and Aitman, Timothy and Alachkar, Hana and Allen, Louise and Allen, Hana Lango and Allsup, David and Ambegaonkar, Gautum and Anderson, Julie and Antrobus, Richard and Armstrong, Ruth and Arumugakani, Gururaj and Ashford, Sofie and Astle, William and Attwood, Antony and Austin, Steve and Bacchelli, Chiara and Bakchoul, Tamam and Bariana, Tadbir K and Baxendale, Helen and Bennett, David and Bethune, Claire and Bibi, Shahnaz and Bitner-Glindzicz, Maria and Bleda, Marta and Boggard, Harm and Bolton-Maggs, Paula and Booth, Claire and Bradley, John R and Brady, Angie and Brown, Matthew and Browning, Michael and Bryson, Christine and Burns, Siobhan and Calleja, Paul and Canham, Natalie and Carmichael, Jenny and Caulfield, Mark and Chalmers, Elizabeth and Chandra, Anita and Chinnery, Patrick and Chitre, Manali and Church, Colin and Clement, Emma and Clements-Brod, Naomi and Clowes, Virginia and Coghlan, Gerry and Collins, Peter and Cooper, Nichola and Creaser-Myers, Amanda and DaCosta, Rosa and Daugherty, Louise and Davies, Sophie and Davis, John and De Vries, Minka and Deegan, Patrick and Deevi, Sri V.V and Deshpande, Charu and Devlin, Lisa and Dewhurst, Eleanor and Doffinger, Rainer and Dormand, Natalie and Drewe, Elizabeth and ... and NIHR Bioresource - Rare Dis and UK Inherited Retinal Dis and UK Inherited Retinal Disease Consortium and NIHR Bioresource - Rare Diseases Consortium
The American Journal of Human Genetics, ISSN 0002-9297, 02/2017, Volume 100, Issue 2, pp. 334 - 342
Journal Article
Movement Disorders, ISSN 0885-3185, 04/2015, Volume 30, Issue 4, pp. 500 - 509
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2011, Volume 50, Issue 1, pp. 73 - 84.e1
Objective To assess the safety and efficacy of ABT-089, a novel α4 β2 neuronal nicotinic receptor partial agonist, vs. placebo in children with... 
Pediatrics | Psychiatry | ADHD | neuronal nicotinic receptor | pharmacologic treatment | α4β2 | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | RECEPTOR AGONISTS | PSYCHOLOGY, DEVELOPMENTAL | alpha 4 beta 2 | ADULTS | SUBUNITS | CHILDREN | ADOLESCENT | PEDIATRICS | ATOMOXETINE | RAT-BRAIN | EXPRESSION | CHRONIC NICOTINE | Diagnostic Tests | Medical Evaluation | Drug Therapy | Scores | Outcomes of Treatment | Attention Deficit Hyperactivity Disorder | Measures (Individuals) | Safety | Children | Physical Examinations | Rating Scales | Symptoms (Individual Disorders) | Adrenergic Uptake Inhibitors - adverse effects | Pyridines - administration & dosage | Double-Blind Method | Humans | Pyrrolidines - administration & dosage | Pyrrolidines - adverse effects | Male | Treatment Outcome | Attention Deficit Disorder with Hyperactivity - drug therapy | Nicotinic Agonists - adverse effects | Nicotinic Agonists - administration & dosage | Psychiatric Status Rating Scales | Pyridines - adverse effects | Propylamines - administration & dosage | Atomoxetine Hydrochloride | Adrenergic Uptake Inhibitors - administration & dosage | Adult | Female | Attention Deficit Disorder with Hyperactivity - diagnosis | Drug Monitoring | Child | Propylamines - adverse effects | Antagonists (Biochemistry) | Evaluation | Care and treatment | Attention-deficit hyperactivity disorder | Attention deficit disorder | Medical research | Hyperactivity | Child & adolescent psychiatry | children
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 4, pp. 971 - 980.e1
Background & Aims Interferon-free treatment options are rapidly evolving for patients with chronic hepatitis C virus (HCV) genotype 1b (GT1b) infection with... 
Gastroenterology and Hepatology | Direct-Acting Antivirals | Interferon-Free/Ribavirin-Free | HCV Genotype 1b | ABT-450/R-OMBITASVIR | CHRONIC HCV | RANDOMIZED-TRIAL | RIBAVIRIN | PEGINTERFERON ALPHA-2A | PLUS SOFOSBUVIR | DASABUVIR | TREATMENT-EXPERIENCED PATIENTS | DACLATASVIR | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Recurrence | Anilides - therapeutic use | United States | Anilides - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Carbamates - administration & dosage | Hepatitis C, Chronic - complications | Enzyme Inhibitors - administration & dosage | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Female | Drug Therapy, Combination | Enzyme Inhibitors - adverse effects | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Ritonavir - administration & dosage | Administration, Oral | Antiviral Agents - therapeutic use | Europe | Carrier Proteins - antagonists & inhibitors | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Enzyme Inhibitors - therapeutic use | Remission Induction | Macrocyclic Compounds - therapeutic use | Hepacivirus - enzymology | Liver Cirrhosis - virology | Anilides - administration & dosage | Antiviral Agents - adverse effects | Carbamates - adverse effects | Aged | Macrocyclic Compounds - administration & dosage | Carbamates - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Virus diseases | Medical research | Proteases | Ritonavir | Analysis | Liver | Medicine, Experimental | Biological response modifiers | Hepatitis C virus | Health aspects | Gangliosides | Liver cirrhosis
Journal Article
by Natarajan, Pradeep and Peloso, Gina M and Zekavat, Seyedeh Maryam and Montasser, May and Ganna, Andrea and Chaffin, Mark and Khera, Amit V and Zhou, Wei and Bloom, Jonathan M and Engreitz, Jesse M and Ernst, Jason and O’Connell, Jeffrey R and Ruotsalainen, Sanni E and Alver, Maris and Manichaikul, Ani and Johnson, W. Craig and Perry, James A and Poterba, Timothy and Seed, Cotton and Surakka, Ida L and Esko, Tonu and Ripatti, Samuli and Salomaa, Veikko and Correa, Adolfo and Vasan, Ramachandran S and Kellis, Manolis and Neale, Benjamin M and Lander, Eric S and Abecasis, Goncalo and Mitchell, Braxton and Rich, Stephen S and Wilson, James G and Cupples, L. Adrienne and Rotter, Jerome I and Willer, Cristen J and Kathiresan, Sekar and Abe, Namiko and Albert, Christine and Allred, Nicholette (Nichole) Palmer and Almasy, Laura and Alonso, Alvaro and Ament, Seth and Anderson, Peter and Anugu, Pramod and Applebaum-Bowden, Deborah and Arking, Dan and Arnett, Donna K and Ashley-Koch, Allison and Aslibekyan, Stella and Assimes, Tim and Auer, Paul and Avramopoulos, Dimitrios and Barnard, John and Barnes, Kathleen and Barr, R. Graham and Barron-Casella, Emily and Beaty, Terri and Becker, Diane and Becker, Lewis and Beer, Rebecca and Begum, Ferdouse and Beitelshees, Amber and Benjamin, Emelia and Bezerra, Marcos and Bielak, Larry and Bis, Joshua and Blackwell, Thomas and Blangero, John and Boerwinkle, Eric and Borecki, Ingrid and Bowler, Russell and Brody, Jennifer and Broeckel, Ulrich and Broome, Jai and Bunting, Karen and Burchard, Esteban and Cardwell, Jonathan and Carty, Cara and Casaburi, Richard and Casella, James and Chang, Christy and Chasman, Daniel and Chavan, Sameer and Chen, Bo-Juen and Chen, Wei-Min and Chen, Yii-Der Ida and Cho, Michael and Choi, Seung Hoan and Chuang, Lee-Ming and Chung, Mina and Cornell, Elaine and Crandall, Carolyn and Crapo, James and Curran, Joanne and Curtis, Jeffrey and Custer, Brian and Damcott, Coleen and Darbar, Dawood and Das, Sayantan and David, Sean and ... and NHLBI TOPMed Lipids Working Grp and NHLBI TOPMed Lipids Working Group
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 3391 - 12
Journal Article
Movement Disorders, ISSN 0885-3185, 4/2015, Volume 30, Issue 4, pp. 500 - 509
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatment and linked to pulsatile dopaminergic stimulation. l... 
levodopa-carbidopa intestinal gel | infusion | percutaneous endoscopic gastrojejunostomy | dyskinesia | “off” time
Journal Article
by Kachroo, Priyadarshini and Hecker, Julian and Chawes, Bo L and Ahluwalia, Tarunveer S and Cho, Michael H and Qiao, Dandi and Kelly, Rachel S and Chu, Su H and Virkud, Yamini V and Huang, Mengna and Barnes, Kathleen C and Burchard, Esteban G and Eng, Celeste and Hu, Donglei and Celedón, Juan C and Daya, Michelle and Levin, Albert M and Gui, Hongsheng and Williams, L. Keoki and Forno, Erick and Mak, Angel C.Y and Avila, Lydiana and Soto-Quiros, Manuel E and Cloutier, Michelle M and Acosta-Pérez, Edna and Canino, Glorisa and Bønnelykke, Klaus and Bisgaard, Hans and Raby, Benjamin A and Lange, Christoph and Weiss, Scott T and Lasky-Su, Jessica A and Abe, Namiko and Abecasis, Goncalo and Albert, Christine and Palmer Allred, Nicholette (Nichole) and Almasy, Laura and Alonso, Alvaro and Ament, Seth and Anderson, Peter and Anugu, Pramod and Applebaum-Bowden, Deborah and Arking, Dan and Arnett, Donna K and Ashley-Koch, Allison and Aslibekyan, Stella and Assimes, Tim and Auer, Paul and Avramopoulos, Dimitrios and Barnard, John and Barnes, Kathleen and Barr, R. Graham and Barron-Casella, Emily and Beaty, Terri and Becker, Diane and Becker, Lewis and Beer, Rebecca and Begum, Ferdouse and Beitelshees, Amber and Benjamin, Emelia and Bezerra, Marcos and Bielak, Larry and Bis, Joshua and Blackwell, Thomas and Blangero, John and Boerwinkle, Eric and Borecki, Ingrid and Bowler, Russell and Brody, Jennifer and Broeckel, Ulrich and Broome, Jai and Bunting, Karen and Burchard, Esteban and Cardwell, Jonathan and Carty, Cara and Casaburi, Richard and Casella, James and Chaffin, Mark and Chang, Christy and Chasman, Daniel and Chavan, Sameer and Chen, Bo-Juen and Chen, Wei-Min and Chen, Yii-Der Ida and Cho, Michael H and Choi, Seung Hoan and Chuang, Lee-Ming and Chung, Mina and Cornell, Elaine and Correa, Adolfo and Crandall, Carolyn and Crapo, James and Cupples, L. Adrienne and Curran, Joanne and Curtis, Jeffrey and Custer, Brian and Damcott, Coleen and Darbar, Dawood and Das, Sayantan and David, Sean and ...
Chest, ISSN 0012-3692, 12/2019, Volume 156, Issue 6, pp. 1068 - 1079
Journal Article